他汀类药物对腹主动脉瘤修复术后总死亡率影响的系统评价与荟萃分析
该系统评价与荟萃分析检索截至2020年2月的文献,纳入14项队列研究(11项高质量),评估他汀治疗对腹主动脉瘤修复术后长期生存的影响。汇总69 790例患者(中位随访3.1年)显示,他汀治疗与总死亡率相对降低35%相关(率比0.65,95%CI 0.57-0.73),异质性中等(I2=68%),无小研究效应。
要点
- 他汀治疗与腹主动脉瘤修复术后总死亡率相对降低35%相关。
- 汇总率比0.65(95%CI 0.57-0.73),异质性中等(I2=68%)。
- 证据来自14项队列研究,其中11项评为高质量。
核心结论
- 他汀治疗对腹主动脉瘤修复术后患者的长期生存具有有益效应。
研究设计与样本
- 系统评价与荟萃分析,纳入14项观察性队列研究,其中11项评为高质量。
- 汇总69 790例腹主动脉瘤修复术后患者,中位随访3.1年。
- 采用随机效应模型合并结果,并通过亚组分析和meta回归分析探讨异质性。
主要发现
- 他汀治疗与总死亡率相对降低35%相关(率比0.65,95%CI 0.57-0.73)。
- 研究间异质性中等(I2=68%),未检测到小研究效应。
关键数值与推荐
- 他汀治疗组总死亡率率比为0.65(95%CI 0.57-0.73),对应相对降低35%。
- 异质性I2=68%,无小研究效应。
临床怎么用
- 在腹主动脉瘤修复术后患者中,可考虑他汀治疗以改善长期生存。
局限性
- 证据基于观察性队列研究,可能存在混杂偏倚。
- 研究间存在中等异质性(I2=68%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim was to summarise the evidence from published epidemiological studies investigating the efficacy of statin therapy on long term survival in patients after abdominal aortic aneurysm (AAA) repair. DATA SOURCES: This study was a systematic review with critical appraisal and meta-analysis of observational studies. REVIEW METHODS: A systematic literature search was carried out throughout February 2020, revealing 14 eligible cohort studies of which 11 were judged to be of high quality. A random effects model was used to synthesise results, and heterogeneity between studies examined by subgroup and meta-regression analyses considering patient and study related variables. Small study effect was evaluated. RESULTS: The pooled estimate showed that statin treatment among 69 790 AAA patients with a median follow up of 3.1 years was associated with a 35% relative reduction in total mortality (rate ratio 0.65, 95% confidence interval 0.57-0.73) with moderate heterogeneity (I2 = 68%) and no small study effect. CONCLUSION: Evidence from this systematic review indicates a beneficial effect of statins on long term survival in patients treated by AAA repair.
引用
- Risum Ø, Sandven I, Sundhagen JO, et al. Editor's Choice - Effect of Statins on Total Mortality in Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2020. PMID: 32928667. doi:10.1016/j.ejvs.2020.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。